Fig. 1From: Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 yearsPosition of pathogenic variants in DCIS cases in a BRCA2, b CHEK2, c PALB2, d BRCA1Back to article page